Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
UnitAid

UNITAID Expert Working Group Meeting on Market Impact and Criteria

Last update: Jul 24, 2015 Last update: Jul 24, 2015

Details

Locations:Africa, Asia, EU 27, Europe Non EU 27, Latin America and the Caribbean, Northern America, Oceania
Start Date:Jan 1, 2009
End Date:Dec 31, 2009
Sectors:Health, Marketing
 Health, Marketing
Categories:Consulting services
Funding Agencies:
UnitAid
Date posted:Dec 3, 2013

Associated funding

Associated experts

Description

UNITAID is a new agency designed to improve the markets for medicines and diagnostics for HIV, TB and malaria. Many products which are important to public health suffer from market failure: they are not available, the quality is poor, they are very expensive, or they are simply not available in poor countries. UNITAID needed to improve the criteria it uses for assessing the market impact of applications for funding. Consequently, two experts from HLSP were invited and prepared papers - one on malaria and one on generic approaches to assessing market impact.

Technical area:

  • Private sector
  • Access to medicines
  • TB, malaria and other communicable diseases.

Client: UNITAID.

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print